Allergic contact dermatitis to latanoprost

Kelly Michele Jerstad, Erin Warshaw

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


An 85-year-old male with glaucoma presented with a 1-1/2 year history of tearing; red eyes; and pruritic, edematous, eczematous eyelids. Treatment for presumed ocular rosacea and seborrhea was unhelpful. Patch testing to our standard 64 antigens yielded a positive reaction to Balsam of Peru. Notably, benzalkonium chloride, thimerosal, and other preservatives elicited negative reactions. Repeat open application testing elicited positive results to Xalatan (latanoprost) 0.005% ophthalmic solution (Pharmacia & Upjohn, Kalamazoo, MI). A second session of patch tests to 10 personal products, in addition to Xalatan 0.005% solution and the Xalatan vehicle (provided by the manufacturer), elicited a strong positive reaction only to the full preparation of Xalatan 0.005% solution. This report describes the first known case of ACD to latanoprost, a new prostaglandin analog that is widely prescribed for treatment of glaucoma.

Original languageEnglish (US)
Pages (from-to)39-41
Number of pages3
JournalUnknown Journal
Issue number1
StatePublished - Jan 1 2002


Dive into the research topics of 'Allergic contact dermatitis to latanoprost'. Together they form a unique fingerprint.

Cite this